Trending...
- Up To 70% Off! Alibonnie Graduation Season Wig Surprise Discount
- Bitcoin Mining Capacity Reaches 350 Exahashes/second
- ReadyCommunities Partnership of CCROA Announces National Service Awardees Who Helped Save Passengers from the Derailed Train Near Rural Mendon
Provides the Opportunity to Sell SafeBreak® Vascular in International Markets
FAYETTEVILLE, Ark. - PRDelivery -- Lineus Medical has been granted Certificates of Registration for both EN IS0 13485:2016 and 13485:2016/MDSAP. These certify that the quality management system of Lineus Medical has been registered as conforming to high caliber, international standards. The certified quality management system applies to the design and development, manufacture, and distribution of SafeBreak Vascular.
The certifications were awarded based on passing a rigorous two stage audit conducted by Intertek, an international quality assurance and audit organization. The certificates allow Lineus Medical to enter into international markets with SafeBreak Vascular, the company's flagship product.
SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer connector in the world, although currently it is only cleared for use in the United States. The device is designed to separate when a damaging force is placed on an IV line, therefore reducing irritation of the vein and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient. In a 2021 randomized controlled trial, SafeBreak Vascular was shown to reduce IV complications requiring an IV restart by 44%.1
More on PR Delivery
"Obtaining these certifications is huge for the organization and is a testament to our high-Quality standards," Will Armstrong, COO of Lineus Medical stated. "We can now continue executing our strategic plan and expand into regions such as Japan, Korea, Canada, and Europe."
SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Over 235M peripheral IVs are successfully placed in the United States each year and over 2B globally1. Peripheral IVs fail 46% of the time2 before their intended use is complete and cost the US healthcare system over $5B annually1.
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other medical tubing may be reduced with a device that breaks into two pieces to protect the patient's medical line. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn or Twitter.
More on PR Delivery
1Data on file.
2Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015; 38(3): 189-203
The certifications were awarded based on passing a rigorous two stage audit conducted by Intertek, an international quality assurance and audit organization. The certificates allow Lineus Medical to enter into international markets with SafeBreak Vascular, the company's flagship product.
SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer connector in the world, although currently it is only cleared for use in the United States. The device is designed to separate when a damaging force is placed on an IV line, therefore reducing irritation of the vein and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient. In a 2021 randomized controlled trial, SafeBreak Vascular was shown to reduce IV complications requiring an IV restart by 44%.1
More on PR Delivery
- Aquia Launches Amazon Web Services (AWS) Cloud Security Assessment Offering, Pairing Automation With Deep Cloud Security Expertise
- Orbex Launches New ZERO Spread Trading Account with $1 Commission per Side
- Alpha Gold Fund Receives Recognition Of Excellence Awards
- Ohio County Commission President & Founder of the Cincinnati Black Music Walk of Fame, Alicia Reece, Announces Grand Opening of New Tourism Attraction
- New York Komedians Presents an Evening of Laughs at Broadway
"Obtaining these certifications is huge for the organization and is a testament to our high-Quality standards," Will Armstrong, COO of Lineus Medical stated. "We can now continue executing our strategic plan and expand into regions such as Japan, Korea, Canada, and Europe."
SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Over 235M peripheral IVs are successfully placed in the United States each year and over 2B globally1. Peripheral IVs fail 46% of the time2 before their intended use is complete and cost the US healthcare system over $5B annually1.
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other medical tubing may be reduced with a device that breaks into two pieces to protect the patient's medical line. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn or Twitter.
More on PR Delivery
- Redefining Professional Spaces: The Rise of Dual-Purpose Backyard Office Sheds in America
- Registration is Now Open for the 2023 CGI Integrated Care Conference
- Studeo dévoile StudAI : l'Intelligence Artificielle au service de l'éducation
- EMH Productions Announce 'Live for Liberty' Charity Concert in Los Angeles Supporting "Woman, Life, Freedom" Movement in Iran
- NEMTAC® Brings Innovation to Accreditation Industry with the Launch of Collaborative Network Built on Distributed Ledger Technology
1Data on file.
2Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015; 38(3): 189-203
Source: Lineus Medical
0 Comments
Latest on PR Delivery
- SafeBreak® Vascular Cleared for Pediatrics
- CartoVista unveils CartoVista Cloud 8.1, the latest in GIS web mapping platforms, at 2023 FCM Conference in Toronto
- CartoVista unveils CartoVista Cloud at the 2023 FCM Conference in Toronto
- Resurgence Wellness Unveils Revolutionary Anti-Aging Breakthroughs by Tech Pioneer Bryan Johnson
- Baked by Michela Announces Grand Opening of Bucks County, Pennsylvania Bakery
- Senco Home Services Rebuilds Tewksbury Baseball Fields
- G. Entertainment Proudly Presents The Hip-hop 50th Anniversary Concert
- Telliant Systems Names Taylor Heath, Director of Business Development
- Sage Intact Launches Native AP Bill Automation to Cut Down on Invoice Processing Time
- Avoiding the Summer Slide: Oakland-Based Children Rising To Provide Summer Enrichment Programming
- U.S. Small Business Advocate Molly Bakewell Chamberlin Selected as Mentor for Buffalo Niagara Medical Campus Innovation Community Success Program
- Make your Business Stand Out with a Memorable and Relevant Name From Namify's Company Name Generator
- Engineers honored at international conference in New Orleans
- Veterans for Trump Spokesman Admiral Charles Kubic signs onto push that DEI be removed from DOD
- Black Dog Venture Partners Acquires 20% Stake in St. Petersburg based, Woman Owned Music Discovery Platform Giggidy
- We Decode DNA Kit Named One of the Top 50 Most Innovative Products of 2023 by Innovation & Tech Today
- New Jewelry Viewing Room at Biris Jewelers
- The US Senators are Getting Satellite Phones for Security, and You Should Too
- Launch of The Who's Who Guide to Asset Tokenization
- Mensa Foundation Prize Awarded to NIH Neuroscientist